Thema
Journal Article
6.977
Research Support, Non-U.S. Gov't
4.687
Research Support, N.I.H., Extramural
2.003
EC 2.7.10.1
1.335
Biomarkers, Tumor
1.222
Antineoplastic Agents
1.127
EC 2.7.11.1
903
Antibodies, Monoclonal, Humanized
786
Antibodies, Monoclonal
682
Research Support, U.S. Gov't, P.H.S.
636
RNA, Messenger
622
Protein Kinase Inhibitors
520
ErbB Receptors
472
Clinical Trial, Phase I
457
Research Support, U.S. Gov't, Non-P.H.S.
456
Neoplasm Proteins
450
Proto-Oncogene Proteins
418
Receptor, ErbB-2
399
DNA-Binding Proteins
391
Comparative Study
380
Tumor Suppressor Protein p53
378
Membrane Proteins
363
Multicenter Study
357
Clinical Trial, Phase II
353
Transcription Factors
342
Nuclear Proteins
328
Tumor Suppressor Proteins
325
Antigens, Neoplasm
306
Review
275
Comment
274
EC 3.6.5.2
265
Cell Cycle Proteins
262
Randomized Controlled Trial
243
Proto-Oncogene Proteins c-akt
241
Vascular Endothelial Growth Factor A
241
Protein Serine-Threonine Kinases
229
Antigens, CD
227
Proto-Oncogene Proteins B-raf
224
Proto-Oncogene Proteins c-bcl-2
223
RNA, Small Interfering
218
EGFR protein, human
217
Membrane Glycoproteins
211
B7-H1 Antigen
209
ERBB2 protein, human
204
TOR Serine-Threonine Kinases
200
BRAF protein, human
198
EC 3.4.22.-
198
Klinische Studie
187
Proto-Oncogene Proteins p21(ras)
187
CD274 protein, human
186
mehr ...